Advertisement
Measuring Medicine Prices
Measuring Medicine Prices
Measuring Medicine Prices
Measuring Medicine Prices

Check these out next

How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
Office of Health Economics
Towse us and eu comparison slides
Towse us and eu comparison slides
Office of Health Economics
PRIME
PRIME
EURORDIS Rare Diseases Europe
HCF 2019 Panel 3: Mike Schade
HCF 2019 Panel 3: Mike Schade
Chemicals Forum Association
Multi-Indication Pricing: Pros, Cons and Applicability to the UK
Multi-Indication Pricing: Pros, Cons and Applicability to the UK
Kerry Sheppard
HCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka Malm
Chemicals Forum Association
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
Office of Health Economics
Enabling General Practice Transformation
Enabling General Practice Transformation
Health Informatics New Zealand
1 of 4

Measuring Medicine Prices

Sep. 12, 2008••
Download to read offline
Health & Medicine
Technology
Business

Presentation on approaches to measure medicine prices and price components, by Marg Ewen, Health Action International, at the launch of the Medicines Transparency Alliance, London 15 May 2008

MeTApresents
Communication & Capacity Strengthening Director
Advertisement
Advertisement
Advertisement

Recommended

Plenary4 b trailPlenary4 b trail
Plenary4 b trailAsszisztencia197 views•17 slides
MeTA Assessment ToolboxMeTA Assessment Toolbox
MeTA Assessment ToolboxMeTApresents544 views•12 slides
HCF 2018 Panel 3: Tala HenryHCF 2018 Panel 3: Tala Henry
HCF 2018 Panel 3: Tala HenryChemicals Forum Association88 views•5 slides
Food Safety: Feedback from breakout session to plenary Food Safety: Feedback from breakout session to plenary
Food Safety: Feedback from breakout session to plenary Independent Science and Partnership Council of the CGIAR 320 views•5 slides
HCF 2019 Panel 3: Daren KellandHCF 2019 Panel 3: Daren Kelland
HCF 2019 Panel 3: Daren KellandChemicals Forum Association96 views•7 slides
HCF 2019 Panel 3: Marco CamboniHCF 2019 Panel 3: Marco Camboni
HCF 2019 Panel 3: Marco CamboniChemicals Forum Association108 views•7 slides

More Related Content

Slideshows for you(20)

How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
Office of Health Economics•1.1K views
Towse us and eu comparison slidesTowse us and eu comparison slides
Towse us and eu comparison slides
Office of Health Economics•1.3K views
PRIMEPRIME
PRIME
EURORDIS Rare Diseases Europe•47 views
HCF 2019 Panel 3: Mike SchadeHCF 2019 Panel 3: Mike Schade
HCF 2019 Panel 3: Mike Schade
Chemicals Forum Association•134 views
Multi-Indication Pricing: Pros, Cons and Applicability to the UKMulti-Indication Pricing: Pros, Cons and Applicability to the UK
Multi-Indication Pricing: Pros, Cons and Applicability to the UK
Kerry Sheppard•106 views
HCF 2017 closing day 2 Jukka MalmHCF 2017 closing day 2 Jukka Malm
HCF 2017 closing day 2 Jukka Malm
Chemicals Forum Association•54 views
The Value of Knowing and Knowing the Value: Improving the Health Technology A...The Value of Knowing and Knowing the Value: Improving the Health Technology A...
The Value of Knowing and Knowing the Value: Improving the Health Technology A...
Office of Health Economics•760 views
Enabling General Practice TransformationEnabling General Practice Transformation
Enabling General Practice Transformation
Health Informatics New Zealand•236 views
Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...
Kathy Talkington and Joe Swedberg - Antibiotic Stewardship – Recent Activitie...
John Blue•48 views
UNDP at The International Healthcare Waste ConferenceUNDP at The International Healthcare Waste Conference
UNDP at The International Healthcare Waste Conference
UN SPHS•758 views
The SPHS Presentation at The International Water Association Conference in Sw...The SPHS Presentation at The International Water Association Conference in Sw...
The SPHS Presentation at The International Water Association Conference in Sw...
UN SPHS•971 views
UNDP at the International conference on Obsolete Pharmaceuticals: Impact on ...UNDP at the International conference on Obsolete Pharmaceuticals: Impact on ...
UNDP at the International conference on Obsolete Pharmaceuticals: Impact on ...
UN SPHS•1.2K views
June 9 2017 Panel 4 Anne GourmelonJune 9 2017 Panel 4 Anne Gourmelon
June 9 2017 Panel 4 Anne Gourmelon
Chemicals Forum Association•61 views
Opportunity costs and local health service spending decisions: A qualitative ...Opportunity costs and local health service spending decisions: A qualitative ...
Opportunity costs and local health service spending decisions: A qualitative ...
Kerry Sheppard•889 views
Interagency Approach to Sustainable Procurement in Health SectorInteragency Approach to Sustainable Procurement in Health Sector
Interagency Approach to Sustainable Procurement in Health Sector
UNDP Eurasia•1.6K views
Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...
Phytothreats WP2: Feasibility analyses and development of ‘best practice’ cri...
Forest Research•198 views
Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...
Logistics and Regulatory Requirements in Collaborative Care of Opioid Use Dis...
VICTOR MAESTRE RAMIREZ•92 views
Increasing Numbers of Launches and Growth in Spending on Specialty Products i...Increasing Numbers of Launches and Growth in Spending on Specialty Products i...
Increasing Numbers of Launches and Growth in Spending on Specialty Products i...
IMS Health US•396 views
June 9 2017 Panel 4 Erika KunzJune 9 2017 Panel 4 Erika Kunz
June 9 2017 Panel 4 Erika Kunz
Chemicals Forum Association•292 views
Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...
Patient Assessment, Screening, and Education for Initiation of Buprenorphine/...
VICTOR MAESTRE RAMIREZ•105 views

Similar to Measuring Medicine Prices(20)

Encouraging best practice and improve the rational use of medicinesEncouraging best practice and improve the rational use of medicines
Encouraging best practice and improve the rational use of medicines
MeTApresents•620 views
0107 Jan Geissler - How drug development works and elements of trial protocols0107 Jan Geissler - How drug development works and elements of trial protocols
0107 Jan Geissler - How drug development works and elements of trial protocols
Workgroup of European Cancer Patient Advocacy Networks•276 views
Drug Purchasing & Pricing : industry perspectiveDrug Purchasing & Pricing : industry perspective
Drug Purchasing & Pricing : industry perspective
Pharmacy @ Institut Kanser Negara•4.4K views
EuroBioForum 2013 - Day 1 | Katherine Payne EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum 2013 - Day 1 | Katherine Payne
EuroBioForum•722 views
Concept and structure of MeTAConcept and structure of MeTA
Concept and structure of MeTA
MeTApresents•517 views
What can we learn from other countries?What can we learn from other countries?
What can we learn from other countries?
Health and Care Innovation Expo•1.1K views
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
Ron Piervincenzi: "USP Standards: Facilitating a fair and competitive marketp...
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics•246 views
RDD 2020 Day 2 AM : Tania StafinskiRDD 2020 Day 2 AM : Tania Stafinski
RDD 2020 Day 2 AM : Tania Stafinski
Canadian Organization for Rare Disorders•182 views
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization Studies
Zarrin Ansari•262 views
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
Dr.Kavitha Vivek•499 views
Challenges to improve medicines transparency in GhanaChallenges to improve medicines transparency in Ghana
Challenges to improve medicines transparency in Ghana
MeTApresents•759 views
Pharma premium pricingPharma premium pricing
Pharma premium pricing
Clearstate•638 views
Promotional drug literature Promotional drug literature
Promotional drug literature
bhagyamohod90•897 views
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
STREAM TWO: Daniel O’Connor, European regulatory approaches to drugs for rare...
Canadian Organization for Rare Disorders•174 views
Post marketing surveillancePost marketing surveillance
Post marketing surveillance
Dhruvi50•250 views
Vientiane Panel Oct08 Salmela V4Vientiane Panel Oct08 Salmela V4
Vientiane Panel Oct08 Salmela V4
IDS•380 views
Paying for performance to improve the delivery of health interventions in LMICsPaying for performance to improve the delivery of health interventions in LMICs
Paying for performance to improve the delivery of health interventions in LMICs
ReBUILD for Resilience•271 views
Pharmacovigilance & WHO Drug Monitoring Program.pptxPharmacovigilance & WHO Drug Monitoring Program.pptx
Pharmacovigilance & WHO Drug Monitoring Program.pptx
Easy Concept •183 views
DUS_Dr. Mansij BiswasDUS_Dr. Mansij Biswas
DUS_Dr. Mansij Biswas
Mansij Biswas•4.8K views
Presentation: Updates from the Therapeutic Goods Administration - For medicin...Presentation: Updates from the Therapeutic Goods Administration - For medicin...
Presentation: Updates from the Therapeutic Goods Administration - For medicin...
TGA Australia•774 views
Advertisement

More from MeTApresents(20)

MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reporting
MeTApresents•815 views
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The Philippines
MeTApresents•1.2K views
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in Peru
MeTApresents•1.1K views
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And Milestones
MeTApresents•1.1K views
MeTA introductionMeTA introduction
MeTA introduction
MeTApresents•750 views
MeTA Core PrinciplesMeTA Core Principles
MeTA Core Principles
MeTApresents•697 views
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosure
MeTApresents•800 views
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in Zambia
MeTApresents•892 views
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in Zambia
MeTApresents•919 views
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in Uganda
MeTApresents•848 views
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reporting
MeTApresents•1.5K views
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendations
MeTApresents•564 views
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processes
MeTApresents•1K views
Data disclosure in JordanData disclosure in Jordan
Data disclosure in Jordan
MeTApresents•837 views
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestones
MeTApresents•868 views
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in Ghana
MeTApresents•512 views
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in Ghana
MeTApresents•781 views
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein Kyrgyzstan
MeTApresents•361 views
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and future
MeTApresents•672 views
MeTA country guidance noteMeTA country guidance note
MeTA country guidance note
MeTApresents•1.5K views

Recently uploaded(20)

labour.pdflabour.pdf
labour.pdf
SurakshyaGyawali2•0 views
jean-piaget.pptjean-piaget.ppt
jean-piaget.ppt
El Viajero•0 views
Martha Stark MD – 5 Jun 2021 – A Heart Shattered and Relentless Despair.pptxMartha Stark MD – 5 Jun 2021 – A Heart Shattered and Relentless Despair.pptx
Martha Stark MD – 5 Jun 2021 – A Heart Shattered and Relentless Despair.pptx
Martha Stark MD•0 views
ppt HIV 2.pptxppt HIV 2.pptx
ppt HIV 2.pptx
InasHanun•0 views
Martha Stark MD – 27 Oct 2017 – The Transformative Power of Optimal Stress.pptxMartha Stark MD – 27 Oct 2017 – The Transformative Power of Optimal Stress.pptx
Martha Stark MD – 27 Oct 2017 – The Transformative Power of Optimal Stress.pptx
Martha Stark MD•0 views
Martha Stark MD – 26 - 27 Apr 2019 – My Psychodynamic Synergy Paradigm – A C....Martha Stark MD – 26 - 27 Apr 2019 – My Psychodynamic Synergy Paradigm – A C....
Martha Stark MD – 26 - 27 Apr 2019 – My Psychodynamic Synergy Paradigm – A C....
Martha Stark MD•0 views
labour 2.pdflabour 2.pdf
labour 2.pdf
SurakshyaGyawali2•0 views
other hormones.pptxother hormones.pptx
other hormones.pptx
Pawan Maharjan•0 views
Health Policy of Pakistan by Irfan.pptxHealth Policy of Pakistan by Irfan.pptx
Health Policy of Pakistan by Irfan.pptx
MuhammadIrfan291463•0 views
Martha Stark MD – Oct 2019 – The Transformative Power of Optimal Stress – Pre...Martha Stark MD – Oct 2019 – The Transformative Power of Optimal Stress – Pre...
Martha Stark MD – Oct 2019 – The Transformative Power of Optimal Stress – Pre...
Martha Stark MD•0 views
jynneos_training_for_vaccinators (2).pptxjynneos_training_for_vaccinators (2).pptx
jynneos_training_for_vaccinators (2).pptx
Maramalahmad1•0 views
NEW NCD GUIDELINE.pptxNEW NCD GUIDELINE.pptx
NEW NCD GUIDELINE.pptx
ImanuIliyas•0 views
CORTEXI.pdfCORTEXI.pdf
CORTEXI.pdf
ssuser9bc024•0 views
Martha Stark MD – 28 Oct 2017 – Relentless Despair – Model 4.pptxMartha Stark MD – 28 Oct 2017 – Relentless Despair – Model 4.pptx
Martha Stark MD – 28 Oct 2017 – Relentless Despair – Model 4.pptx
Martha Stark MD•0 views
Martha Stark MD – 16 Jun 2017 – The Transformative Power of Optimal Stress.pptxMartha Stark MD – 16 Jun 2017 – The Transformative Power of Optimal Stress.pptx
Martha Stark MD – 16 Jun 2017 – The Transformative Power of Optimal Stress.pptx
Martha Stark MD•0 views
gluteal_region_and_back_thigh_gk.pdfgluteal_region_and_back_thigh_gk.pdf
gluteal_region_and_back_thigh_gk.pdf
tuhinsingh•0 views
Martha Stark MD – 26 Jun 2009 – Murmur of the Heart.pptxMartha Stark MD – 26 Jun 2009 – Murmur of the Heart.pptx
Martha Stark MD – 26 Jun 2009 – Murmur of the Heart.pptx
Martha Stark MD•0 views
approachtohistorytakinginapatientwithfever-121012050419-phpapp02.pdfapproachtohistorytakinginapatientwithfever-121012050419-phpapp02.pdf
approachtohistorytakinginapatientwithfever-121012050419-phpapp02.pdf
SoumikTousif•0 views
Unit 2_Acute Rheumatic Fever.pptxUnit 2_Acute Rheumatic Fever.pptx
Unit 2_Acute Rheumatic Fever.pptx
ImanuIliyas•0 views
RV IVP.pptxRV IVP.pptx
RV IVP.pptx
ShreyThakkar7•0 views
Advertisement

Measuring Medicine Prices

  1. Measuring medicine prices, availability, affordability and price components Margaret Ewen Health Action International
Advertisement